Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | N6-methyladenosine | 3902 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | N6-methyladenosine | 3902 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | N6-methyladenosine | 3902 | drug-path |
| Shigellosis | 0 | map05131 | N6-methyladenosine | 3902 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | N6-methyladenosine | 3902 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | N6-methyladenosine | 3902 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | N6-methyladenosine | 3902 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | chlorprothixene | 667467 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | chlorprothixene | 667467 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | cefalexin | 6466 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | cefalexin | 6466 | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | cefalexin | 6466 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cefalexin | 6466 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | cefalexin | 6466 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cefalexin | 6466 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | cefalexin | 6466 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | cefalexin | 6466 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | cefalexin | 6466 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | bepridil | 2351 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | bepridil | 2351 | drug-path |